September 13, 2018 | Washington, DC



an externally-led Patient-Focused Drug Development Workshop:

chemotherapy-induced hearing loss

in pediatric oncology


meeting details


 September 13, 2018 -- Hyattsville, MD

view the webcast recording here.

meeting objectives:

The half-day meeting followed the FDA model for externally-led PFDD meetings and featured a series of facilitated panel and audience discussions, and a webinar with live polling focused on providing the FDA and other stakeholders with patient views on key issues such as:

  • Burden of the condition (physical, emotional, financial issues) impacting daily health-related quality of life;

  • Assessments of current and potential future treatments;

  • Benefits that patients with chemotherapy-induced hearing loss are looking for in treatments and the risks they are willing to assume in return for more advanced interventions;

  • Participation in clinical trials and ideas on trial design to make them more appealing to people with chemotherapy-induced hearing loss.